Cibc World Market Inc. Novartis Ag Transaction History

Cibc World Market Inc.

  • $48 Billion
  • Q3 2024

A detailed history of Cibc World Market Inc. transactions in Novartis Ag stock. As of the latest transaction made, Cibc World Market Inc. holds 49,048 shares of NVS stock, worth $5.09 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
49,048
Previous 49,257 0.42%
Holding current value
$5.09 Million
Previous $5.24 Million 7.59%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$106.13 - $120.89 $22,181 - $25,266
-209 Reduced 0.42%
49,048 $5.64 Million
Q2 2024

Aug 07, 2024
SELL
$92.57 - $107.37 $139,965 - $162,343
-1,512 Reduced 2.98%
49,257 $5.24 Million
Q1 2024

May 13, 2024
SELL
$95.27 - $108.47 $229,695 - $261,521
-2,411 Reduced 4.53%
50,769 $4.91 Million
Q4 2023

Feb 13, 2024
SELL
$92.27 - $101.54 $5.82 Million - $6.41 Million
-63,100 Reduced 54.27%
53,180 $5.37 Million
Q3 2023

Nov 13, 2023
SELL
$94.73 - $105.13 $1.35 Million - $1.5 Million
-14,270 Reduced 10.93%
116,280 $11.2 Million
Q2 2023

Aug 11, 2023
BUY
$92.52 - $104.91 $56,807 - $64,414
614 Added 0.47%
130,550 $13.2 Million
Q1 2023

May 12, 2023
SELL
$80.03 - $92.81 $131,409 - $152,394
-1,642 Reduced 1.25%
129,936 $12 Million
Q4 2022

Feb 13, 2023
BUY
$75.55 - $92.52 $4,079 - $4,996
54 Added 0.04%
131,578 $11.9 Million
Q3 2022

Nov 10, 2022
SELL
$74.61 - $87.26 $287,397 - $336,125
-3,852 Reduced 2.85%
131,524 $10 Million
Q2 2022

Aug 10, 2022
SELL
$80.52 - $93.75 $95,657 - $111,375
-1,188 Reduced 0.87%
135,376 $11.4 Million
Q1 2022

May 12, 2022
SELL
$80.11 - $90.62 $968,770 - $1.1 Million
-12,093 Reduced 8.13%
136,564 $12 Million
Q4 2021

Feb 14, 2022
BUY
$79.7 - $88.13 $18,888 - $20,886
237 Added 0.16%
148,657 $13 Million
Q3 2021

Nov 12, 2021
SELL
$81.78 - $95.14 $75,074 - $87,338
-918 Reduced 0.61%
148,420 $12.1 Million
Q2 2021

Aug 12, 2021
BUY
$85.24 - $94.15 $424,069 - $468,396
4,975 Added 3.45%
149,338 $13.6 Million
Q1 2021

May 11, 2021
BUY
$83.5 - $98.47 $342,016 - $403,333
4,096 Added 2.92%
144,363 $12.3 Million
Q4 2020

Feb 08, 2021
BUY
$78.07 - $94.43 $1.68 Million - $2.03 Million
21,470 Added 18.07%
140,267 $13.2 Million
Q3 2020

Nov 12, 2020
BUY
$82.14 - $91.0 $701,311 - $776,958
8,538 Added 7.74%
118,797 $10.3 Million
Q2 2020

Aug 13, 2020
BUY
$80.93 - $91.1 $361,999 - $407,490
4,473 Added 4.23%
110,259 $9.63 Million
Q1 2020

May 15, 2020
BUY
$70.67 - $99.01 $2.42 Million - $3.38 Million
34,173 Added 47.72%
105,786 $8.72 Million
Q4 2019

Feb 13, 2020
BUY
$84.35 - $95.37 $278,270 - $314,625
3,299 Added 4.83%
71,613 $6.78 Million
Q3 2019

Nov 13, 2019
BUY
$85.54 - $94.26 $87,421 - $96,333
1,022 Added 1.52%
68,314 $5.94 Million
Q2 2019

Aug 08, 2019
BUY
$75.4 - $92.8 $264,880 - $326,006
3,513 Added 5.51%
67,292 $6.14 Million
Q1 2019

May 09, 2019
SELL
$75.32 - $86.15 $3.29 Million - $3.76 Million
-43,702 Reduced 40.66%
63,779 $5.39 Million
Q4 2018

Feb 13, 2019
SELL
$73.66 - $82.02 $134,355 - $149,604
-1,824 Reduced 1.67%
107,481 $9.22 Million
Q3 2018

Nov 09, 2018
SELL
$66.94 - $77.43 $95,925 - $110,957
-1,433 Reduced 1.29%
109,305 $9.42 Million
Q2 2018

Aug 08, 2018
BUY
$64.91 - $73.36 $1.46 Million - $1.65 Million
22,485 Added 25.48%
110,738 $8.37 Million
Q1 2018

May 18, 2018
BUY
$70.39 - $84.15 $3.84 Million - $4.59 Million
54,512 Added 161.56%
88,253 $7.14 Million
Q4 2017

Feb 01, 2018
BUY
$72.33 - $77.64 $428,410 - $459,861
5,923 Added 21.29%
33,741 $2.83 Million
Q3 2017

Nov 13, 2017
BUY
$74.14 - $77.27 $2.06 Million - $2.15 Million
27,818
27,818 $2.39 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Cibc World Market Inc. Portfolio

Follow Cibc World Market Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email